Stanley-Laman Group’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-30,815	Closed	-$256K	–	281
2019 Q2	$256K	Buy	+30,815	New	+$256K	0.06%	247